CAPTRUST Financial Advisors’s Pulse Biosciences PLSE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-8,311
Closed -$13K 3501
2022
Q2
$13K Buy
8,311
+1,768
+27% +$4.45K ﹤0.01% 3613
2022
Q1
$32K Sell
6,543
-21
-0.3% -$172 ﹤0.01% 3105
2021
Q4
$97K Hold
6,564
﹤0.01% 2188
2021
Q3
$142K Hold
6,564
﹤0.01% 1801
2021
Q2
$108K Hold
6,564
﹤0.01% 1976
2021
Q1
$155K Sell
6,564
-479
-7% -$14.3K ﹤0.01% 1657
2020
Q4
$168K Buy
7,043
+175
+3% +$2.78K ﹤0.01% 1265
2020
Q3
$80K Hold
6,868
﹤0.01% 1435
2020
Q2
$70K Buy
+6,868
New +$61.8K ﹤0.01% 1486
2019
Q4
Sell
-1,500
Closed -$23K 1582
2019
Q3
$23K Hold
1,500
﹤0.01% 1263
2019
Q2
$20K Hold
1,500
﹤0.01% 1276
2019
Q1
$26K Buy
+1,500
New +$23.5K ﹤0.01% 1089

Other funds holding PLSE

CAPTRUST Financial Advisors's PLSE Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of Pulse Biosciences (PLSE) in Q3 2022, closing a stake of 8,311 shares — an estimated $13K sold.

CAPTRUST Financial Advisors first reported a position in PLSE in Q1 2019 and held it in 12 quarters. The position peaked at $168K in Q4 2020. 31 funds tracked by Wall St. Rank hold PLSE as of Q3 2022.

  • CAPTRUST Financial Advisors reported no remaining Pulse Biosciences position as of Q3 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 8,311 Pulse Biosciences shares in Q3 2022, an estimated $13K.
  • CAPTRUST Financial Advisors first reported a position in Pulse Biosciences in Q1 2019 and held it in 12 quarters.
  • CAPTRUST Financial Advisors's Pulse Biosciences position peaked at $168K in Q4 2020.
  • 31 funds tracked by Wall St. Rank held Pulse Biosciences as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.